Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The new millennium for adjuvant therapy in breast cancer.

Oncology (Williston Park, N.Y.) - 1 May 2008

Sledge George W

Abstract excerpt

The treatment of microscopic metastatic breast cancer with adjuvant systemic therapy has undergone significant changes in recent years. At the same time, our understanding of the biology of breast cancer has also improved, predominantly as a consequence of data obtained from cDNA microarrays. Breast cancer genomic analyses now suggest that current breast cancer systemic therapies have a profound biologic basis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antineoplastic Agents
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Clinical Trials as Topic

Share to Genetic Predisposition to Disease

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 18561550

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The new millennium for adjuvant therapy in breast cancer.PMID 18561550Read ↗

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancerSemantic proximity Read ↗

Advances in systemic therapy for metastatic breast cancer: future perspectives.Semantic proximity Read ↗

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategiesSemantic proximity Read ↗

Past, present, and future challenges in breast cancer treatment.Semantic proximity Read ↗

[Breast cancer: major therapeutic advances but mortality remains high].Semantic proximity Read ↗

Triple Negative Breast Cancer Treatment Options and Limitations: Future OutlookSemantic proximity Read ↗

Advances in breast cancer detection and management.Semantic proximity Read ↗

[Novel target therapies used in breast cancer management].Semantic proximity Read ↗

Personalized medicine: present and future of breast cancer management.Semantic proximity Read ↗

Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review on the Adjuvant Combinations JourneySemantic proximity Read ↗

Targeted therapies for breast cancer.Semantic proximity Read ↗

How I treat endocrine-dependent metastatic breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.